V

2021 ASCO Update From the ARROW Trial: Clinical Activity and Safety of the RET Inhibitor Pralsetinib in Patients With RET Fusion-Positive Solid Tumors

By Vivek Subbiah 6 Videos
0 views
June 29, 2021
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
24:44
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Successes and Challenges of Early Drug Development for Brain Metasta…

Feat. A. Drilon
29:07
Oncology Data Advisor

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forw…

Feat. J. Mouabbi, R. Maclean, M. Glover
15:31
Shivaani Kummar

Clinical Implications of Tumor Agnostic Therapies

12:22
Melanoma Bridge 2023

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Feat. I. Puzanov
50:11
UNC Lineberger Comprehensive Cancer Center

Integrating Germline Pharmacogenomic Testing Into Oncology Care

Feat. A. Cipriani
34:57
Total Health

2023 ASCO® Direct Philadelphia: Complementary & Integrative Ther…

Feat. B. DuPree
11:51
ecancer

The Common Sense Movement in Oncology

Feat. V. Vanderpuye
09:58
Melanoma Bridge 2023

Drug Development in Melanoma: Why Do We Need Novel Trial Designs?

Feat. M. Khasraw
53:58
Masonic Cancer Center, University of Minnesota

Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experienc…

Feat. D. Largaespada
20:03
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Developing Novel Classes of Therapeutics: Walking a Tightrope Withou…

Feat. K. High
53:57
University of Colorado Cancer Center

What Will It Take to Cure Cancer? Historical Context and Future Dire…

Feat. C. Lieu
27:17
Yale Cancer Center

The Evolution of HIPEC in the Treatment of Cancer

Feat. K. Turaga
30:04
Total Health

2023 ASCO® Direct Philadelphia: Artificial Intelligence in Cancer Ca…

Feat. A. Loaiza-Bonilla
22:43
Oncology Data Advisor

Understanding the Tumor Microenvironment to Unlock the Key to Oncolo…

Feat. J. Garcia
25:05
2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Consider Buprenorphine Based on Clinical Utility and Safety

Feat. A. Case
10:43
University of Colorado Cancer Center

MET Signaling in NSCLC: Importance of Biomarker Development & Ba…

Feat. T. Patil
26:02
Indy Hematology Review

Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…

Feat. K. Orbaugh
15:36
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Curative Therapy for MM: What Have We Learned so Far, and How Does I…

Feat. A. Jakubowiak
26:45
2023 Johns Hopkins Updates in Gastrointestinal Cancers

2023 Johns Hopkins Updates in Gastrointestinal Cancers: Navigating C…

Feat. M. Pishvaian
08:10
ecancer

The Placebo Effect in Oncology Trials and the Criteria for Approving…

Feat. B. Gyawali